Research Focus

Former Employee. NONDIVISIONAL COST; Converted Retiree

Recent additions – View all

1. Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals

   Journal Article

   Young, C. W.; Fanucchi, M. P.; Walsh, T. D.; Baltzer, L.; Yaldaei, S.; Stevens, Y. W.; Gordon, C.; Tong, W.; Rifkind, R. A.; Marks, P. A.
   Cancer Research (1988)

   Fulltext@MSK | Save
2. Phase I trial of N-phosphonacetyl-L-aspartate (PALA), methotrexate (MTX), 5-fluorouracil (FU), and leucovorin (LV) in advanced colorectal cancer (CRC)

   Meeting Abstract

   Kemeny, N.; Reichman, B.; Gordon, C.; Ellison, S.; Deonarine, S.; Slavik, B.; Martin, D.; Young, C.
   Proceedings of the American Association for Cancer Research Annual Meeting (1987)

   Fulltext@MSK | Save